Exhibit 99.1
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507
Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com |
February 14, 2020
Corporate Relationship Department | National Stock Exchange of India Ltd. |
BSE Limited | “Exchange Plaza” |
Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), |
Mumbai – 400 001 | Mumbai – 400 051 |
Fax Nos.: 022-22723121 / 22723719 / | Fax Nos.: 022-26598120/ 26598237/ |
22722037 / 22722039 | 26598238 |
|
|
Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
Dear Sirs,
Sub: Intimation
This is to inform you that the audit of our Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US FDA, has been completed today with zero observation.
This is for your information.
With regards,
/s/ Vikas Sabharwal |
|
Vikas Sabharwal |
|
Assistant Company Secretary |
|
CC:- New York Stock Exchange Inc.(Stock Code :RDY)